May 22, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Date: May 22, 2020 To: Health Plan of San Joaquin (HPSJ) Physicians, Providers, and Pharmacies From: HPSJ Pharmacy and Therapeutics Committee Subject: Formulary Update Business: Medi-Cal Effective August 3, 2020, the Pharmacy and Therapeutics Committee has approved the following changes. Additions to the Formulary: 1. Dulaglutide (Trulicity) 0.75 mg/0.5 mL, 1.5mg/0.5ml pen: PA required. Reserved [...]
Read more
Health Plan of San Joaquin provider Alerts
Immediate Action Required – Epinephrine Auto Injector Devices
June 18, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Date: June 17, 2020 To: Health Plan of San Joaquin (HPSJ) Pharmacies and Providers & Practices From: HPSJ Pharmacy Department Subject: Immediate Action Required – Epinephrine Auto Injector Devices Business: Medi-Cal We are sending this alert because your patient(s) may have filled a prescription for Epinephrine Auto-Injector Device since December 20, 2018. FDA is alerting […]
Read more
Join HPSJ for a web conference on June 25, 2020 at 7:30 am!
June 10, 2020 / by Health Plan / Alerts
HOW MUCH DO YOU KNOW ABOUT DEPARTMENT OF HEALTH CARE SERVICES VALUE BASED PAYMENT (VBP) PROGRAM? Let HPSJ help you and your staff identify key steps to participate! Thursday, June 25, 2020 at 7:30 am Register Now If your practice is focused on delivering quality services and interested in increasing your earning potential, we encourage [...]Read more
Clinical Guideline: Reproductive Health in Rheumatic and Musculoskeletal Diseases
June 3, 2020 / by Health Plan / Alerts, Pharmacy Announcements
The American College of Rheumatology recently published the organization’s first guideline on how to manage reproductive health issues in patients with rheumatic and musculoskeletal diseases (RMDs). Patients with RMDs face unique challenges as pregnancy may be associated with serious maternal or adverse fetal outcomes; furthermore, it is difficult to avoid use of medications in patients […]
Read more
NP Thyroid recall provider alert
May 29, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Date: May 28, 2020 To: Health Plan of San Joaquin (HPSJ) Pharmacies and Providers From: HPSJ Pharmacy Department Subject: NP Thyroid Recall Business: Medi-Cal We are sending this alert because your patients may have filled a prescription for NP Thyroid 30mg, 60mg or 90mg within the last six months (180 days). With FDA knowledge, Acella […]
Read more
Formulary Update Effective 8/3/2020
May 22, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Date: May 22, 2020 To: Health Plan of San Joaquin (HPSJ) Physicians, Providers, and Pharmacies From: HPSJ Pharmacy and Therapeutics Committee Subject: Formulary Update Business: Medi-Cal Effective August 3, 2020, the Pharmacy and Therapeutics Committee has approved the following changes. Additions to the Formulary: 1. Dulaglutide (Trulicity) 0.75 mg/0.5 mL, 1.5mg/0.5ml pen: PA required. Reserved [...]Read more
Value Based Payment (VBP) program – Training Coming Soon – Register Today!
May 12, 2020 / by Health Plan / Alerts
Date: May 12, 2020 To: Health Plan of San Joaquin (HPSJ) Contracted Physicians From: Health Plan of San Joaquin Subject: Value Based Payment (VBP) program – Training Coming Soon – Register Today! Dear Health Plan of San Joaquin Contracted Provider, Health Plan of San Joaquin (HPSJ) is pleased to announce that the Department of Health […]
Read more
Non-Emergency Medical Transportation Billing Requirements
May 8, 2020 / by Health Plan / Alerts, Non-Contracted Provider
Date: May 7, 2020 To: Health Plan of San Joaquin (HPSJ) NEMT Providers From: HPSJ Claims Department Subject: Non-Emergency Medical Transportation Billing Requirements Business: Medi-Cal Managed Care In accordance with Medi-Cal and California Department of Health Care Services (DHCS) guidelines, the following information outlines the billing requirements for all Non-Emergency Medical Transportation (NEMT) providers. Name […]
Read more
Drug Safety Communication: Withdrawal of All Ranitidine Products
May 5, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Drug Safety Communication: Withdrawal of All Ranitidine Products Ranitidine is a histamine-2 blocker commonly used as an over-the-counter (OTC) medication to relieve and prevent heartburn. Prescription-strength ranitidine is also used to treat and prevent more serious ulcers in the stomach and intestines. On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested a […]
Read more
Improving Quality of Care: Update of Risks Associated with Use of Fluoroquinolones
May 5, 2020 / by Health Plan / Alerts, Pharmacy Announcements
Learning Objectives: Describe the recent U.S. Food and Drug Administration (FDA) drug safety communications for fluoroquinolones. Identify potential adverse effects associated with use of fluoroquinolones. Summarize best practices for responsible prescribing of fluoroquinolones. Key Points: Fluoroquinolones are broad-spectrum antibiotics that are FDA-approved to treat various bacterial infections, including infections caused by gram-negative bacilli. Over the […]
Read more
Claims Corner – A newsletter brought to you by Health Plan of San Joaquin – April 23
April 24, 2020 / by Health Plan / Alerts, Claims Corner, Non-Contracted Provider
In this issue: FAQs for this COVID Moment More Helpful Information Reminders Questions about Coronavirus COVID-19? STAY INFORMED FREQUENTLY ASKED QUESTIONS When conducted over the phone, should providers bill their Evaluation and Management (E/M) Office Visits as previously instructed? YES. See #1 & #2 in MORE HELPFUL INFORMATION below. How should providers bill follow-ups, lab [...]Read more